Wei, H., Zhou, C., Lin, D., Liu, B., Li, Y., Zhao, X., Wei, S., Gong, B., Liu, K., Gong, X., Liu, Y., Zhang, G., Chen, J., Zhang, J., Jin, J., Qiu, S., Gu, R., Wang, Y., Mi, Y. and Wang, J. (2021) “Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia”, Haematologica. Pavia, Italy, 106(5), pp. 1491-1495. doi: 10.3324/haematol.2020.267526.